抗甲状腺薬の世界市場レポート 2025年

抗甲状腺薬の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR2.7％で27億8,000万米ドルに成長します。予測期間の成長は、患者の意識と教育、ヘルスケア支出、患者の人口動態、世界の経済状況に起因します。予測期間の主な動向には、甲状腺手術や放射性ヨード代替療法、患者中心の医療、遠隔医療、遠隔モニタリングなどがあります。

甲状腺機能亢進症の主な原因であるバセドウ病の罹患率の増加が抗甲状腺薬市場の成長に寄与しています。バセドウ病は先進諸国に多く、甲状腺機能亢進症の最も一般的な原因です。バセドウ病は主に30～60歳代に発症し、女性は男性の5～10倍発症しやすいです。バセドウ病のリスクには遺伝的要因が大きく関与しており、環境要因の役割は小さいです。バセドウ病や甲状腺機能亢進症と診断される人の増加に伴い、抗甲状腺薬の需要も増加し、市場の成長を牽引しています。

甲状腺がんの有病率の増加は、抗甲状腺薬市場の成長を促進すると予想されます。甲状腺がんは、さまざまな身体機能の調整を担う甲状腺に影響を及ぼします。抗甲状腺薬は甲状腺がんの早期発見と管理に重要な役割を果たし、治療成績を改善する可能性があります。甲状腺がんの有病率が上昇するにつれて、抗甲状腺薬を含む診断ツールに対する需要も増加しています。例えば、2023年には米国で推定4万3,720人の成人が甲状腺がんと診断され、2,120人の死亡が予想されます。この甲状腺がんの有病率の増加が抗甲状腺薬市場の成長に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界抗甲状腺薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の抗甲状腺薬市場：成長率分析
• 世界の抗甲状腺薬市場の実績：規模と成長, 2019-2024
• 世界の抗甲状腺薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界抗甲状腺薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の抗甲状腺薬市場薬剤の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• チオナミド（ホルモン合成阻害）
• ヨウ化物（ホルモン放出の抑制）
• 世界の抗甲状腺薬市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 静脈内
• その他の投与経路
• 世界の抗甲状腺薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 卸売業者または販売業者
• 小売チェーン
• オンライン配信
• その他の流通チャネル
• 世界の抗甲状腺薬市場、チオナミド（ホルモン合成阻害）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• メチマゾール
• プロピルチオウラシル
• 世界の抗甲状腺薬市場、ヨウ化物（ホルモン放出阻害）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヨウ化カリウム
• ルゴールヨウ素液

第7章 地域別・国別分析

• 世界の抗甲状腺薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の抗甲状腺薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 抗甲状腺薬市場：競合情勢
• 抗甲状腺薬市場：企業プロファイル
  • Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Pfizer Inc.
• Allergan plc
• RLC LABS Inc.
• Amgen Inc.
• Lannett Company Inc.
• Sanofi S.A.
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Eli Lilly and Company
• Aspen Pharmacare Holdings Limited
• Astellas Pharma Inc.
• Takeda Pharmaceutical Company Limited
• Boehringer Ingelheim GmbH
• Daiichi Sankyo Company Limited
• Roche Holding AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 抗甲状腺薬市場2029：新たな機会を提供する国
• 抗甲状腺薬市場2029：新たな機会を提供するセグメント
• 抗甲状腺薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Anti-thyroid drugs are a category of medications that operate by either inhibiting the production of thyroid hormones or by reducing the effects of thyroid hormones. They are commonly prescribed for various purposes, including radioactive iodine uptake tests to evaluate thyroid function and to protect the thyroid gland in cases of radiation exposure.

The primary classes of anti-thyroid drugs include thionamides, which work by inhibiting hormone synthesis, and iodides, which inhibit hormone release. These drugs are typically administered through oral and intravenous routes and are distributed through various channels, including wholesalers, retail chains, and online distribution, among others.

The anti-thyroid drugs market research report is one of a series of new reports from The Business Research Company that provides anti-thyroid drugs market statistics, including anti-thyroid drugs industry global market size, regional shares, competitors with an anti-thyroid drugs market share, detailed anti-thyroid drugs market segments, market trends and opportunities, and any further data you may need to thrive in the anti-thyroid drugs industry. This anti-thyroid drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anti-thyroid drugs market size has grown steadily in recent years. It will grow from $2.44 billion in 2024 to $2.5 billion in 2025 at a compound annual growth rate (CAGR) of 2.2%. The growth in the historic period can be attributed to prevalence of thyroid disorders, advancements in drug development, healthcare infrastructure.

The anti-thyroid drugs market size is expected to see steady growth in the next few years. It will grow to $2.78 billion in 2029 at a compound annual growth rate (CAGR) of 2.7%. The growth in the forecast period can be attributed to patient awareness and education, healthcare expenditure, patient demographics, global economic conditions. Major trends in the forecast period include thyroid surgery and radioactive iodine alternatives, patient-centric care, telemedicine and remote monitoring.

The increasing incidence of Graves' disease, which is a leading cause of hyperthyroidism, is contributing to the growth of the anti-thyroid drugs market. Graves' disease is more prevalent in developed countries and is the most common cause of hyperthyroidism. It primarily affects individuals between the ages of 30 and 60, with women being 5-10 times more likely to develop the condition than men. Genetic factors contribute significantly to the risk of Graves' disease, with environmental factors playing a smaller role. As the number of people diagnosed with Graves' disease and hyperthyroidism rises, there is a corresponding increase in the demand for anti-thyroid drugs, thereby driving the market's growth.

The increasing prevalence of thyroid cancer is expected to drive the growth of the anti-thyroid drugs market. Thyroid cancer affects the thyroid gland, which is responsible for regulating various bodily functions. Anti-thyroid drugs play a crucial role in the early detection and management of thyroid cancer, potentially improving treatment outcomes. As the prevalence of thyroid cancer rises, the demand for diagnostic tools, including anti-thyroid drugs, increases. For instance, in 2023, an estimated 43,720 adults in the United States were diagnosed with thyroid cancer, with 2,120 expected deaths attributed to the disease. This increasing prevalence of thyroid cancer is contributing to the growth of the anti-thyroid drugs market.

Various associations dedicated to thyroid care are taking proactive steps to raise awareness about thyroid disorders, recent treatment approaches, and research findings in this field. In the United States, a significant portion of the population with hyperthyroidism remains undiagnosed, with nearly 60% unaware of their condition. Organizations like the American Thyroid Association (ATA) are playing a crucial role in educating the public about thyroid disorders, with a particular focus on hyperthyroidism. Similarly, the Thyroid Foundation of Canada is actively engaged in awareness initiatives to inform the public and foster understanding of various thyroid diseases, including hyperthyroidism. Additional associations, such as the American Academy of Otolaryngology and the British Thyroid Foundation, are also launching awareness programs and initiatives in this regard. These efforts are aimed at increasing knowledge and understanding of thyroid conditions and promoting early diagnosis and effective management.

Major companies operating in the anti-thyroid drugs market are focusing on innovating products, such as Levothyroxine Sodium Injection, to provide reliable services to customers. Levothyroxine Sodium Injection is an injection form of anti-thyroid drug used for treatment of myxedema coma which is a condition of severe hypothyroidism. For instance, in December 2022, Hikma Pharmaceuticals PLC, a UK-based pharmaceutical company, launched Levothyroxine Sodium Injection. Levothyroxine Sodium Injection is medicine used in hospitals for the treatment of thyroid disorders. It is a ready-to-use vials that benefit patients by providing a more convenient and efficient way to administer the medication in hospitals.

Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline PLC, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan PLC, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

North America was the largest region in the anti-thyroid drugs market in 2024. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the anti-thyroid drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anti-thyroid drugs market consists of sales of levothyroxine, propylthiouracil, and methimazole. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anti-Thyroid Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anti-thyroid drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anti-thyroid drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-thyroid drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis); Iodides (Inhibition Of Hormone Release)
• 2) By Route of Administration: Oral; Intravenous; Other Route Of Administration
• 3) By Distribution Channel: Wholesaler Or Distributors; Retail Chain; Online Distribution; Other Distribution Channels
• Subsegments:
• 1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole; Propylthiouracil
• 2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide; Lugol's Iodine Solution
• Companies Mentioned: Mylan N.V.; Abbott Laboratories; GlaxoSmithKline plc; Merck & Co.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Anti-Thyroid Drugs Market Characteristics

3. Anti-Thyroid Drugs Market Trends And Strategies

4. Anti-Thyroid Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Anti-Thyroid Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Anti-Thyroid Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Anti-Thyroid Drugs Market Growth Rate Analysis
• 5.4. Global Anti-Thyroid Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Anti-Thyroid Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Anti-Thyroid Drugs Total Addressable Market (TAM)

6. Anti-Thyroid Drugs Market Segmentation

• 6.1. Global Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thionamides (Inhibition Of Hormone Synthesis)
• Iodides (Inhibition Of Hormone Release)
• 6.2. Global Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Other Route Of Administration
• 6.3. Global Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wholesaler Or Distributors
• Retail Chain
• Online Distribution
• Other Distribution Channels
• 6.4. Global Anti-Thyroid Drugs Market, Sub-Segmentation Of Thionamides (Inhibition Of Hormone Synthesis), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Methimazole
• Propylthiouracil
• 6.5. Global Anti-Thyroid Drugs Market, Sub-Segmentation Of Iodides (Inhibition Of Hormone Release), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Potassium Iodide
• Lugol's Iodine Solution

7. Anti-Thyroid Drugs Market Regional And Country Analysis

• 7.1. Global Anti-Thyroid Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Anti-Thyroid Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anti-Thyroid Drugs Market

• 8.1. Asia-Pacific Anti-Thyroid Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anti-Thyroid Drugs Market

• 9.1. China Anti-Thyroid Drugs Market Overview
• 9.2. China Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anti-Thyroid Drugs Market

• 10.1. India Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anti-Thyroid Drugs Market

• 11.1. Japan Anti-Thyroid Drugs Market Overview
• 11.2. Japan Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anti-Thyroid Drugs Market

• 12.1. Australia Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anti-Thyroid Drugs Market

• 13.1. Indonesia Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anti-Thyroid Drugs Market

• 14.1. South Korea Anti-Thyroid Drugs Market Overview
• 14.2. South Korea Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anti-Thyroid Drugs Market

• 15.1. Western Europe Anti-Thyroid Drugs Market Overview
• 15.2. Western Europe Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anti-Thyroid Drugs Market

• 16.1. UK Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anti-Thyroid Drugs Market

• 17.1. Germany Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anti-Thyroid Drugs Market

• 18.1. France Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anti-Thyroid Drugs Market

• 19.1. Italy Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anti-Thyroid Drugs Market

• 20.1. Spain Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anti-Thyroid Drugs Market

• 21.1. Eastern Europe Anti-Thyroid Drugs Market Overview
• 21.2. Eastern Europe Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anti-Thyroid Drugs Market

• 22.1. Russia Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anti-Thyroid Drugs Market

• 23.1. North America Anti-Thyroid Drugs Market Overview
• 23.2. North America Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anti-Thyroid Drugs Market

• 24.1. USA Anti-Thyroid Drugs Market Overview
• 24.2. USA Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anti-Thyroid Drugs Market

• 25.1. Canada Anti-Thyroid Drugs Market Overview
• 25.2. Canada Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anti-Thyroid Drugs Market

• 26.1. South America Anti-Thyroid Drugs Market Overview
• 26.2. South America Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anti-Thyroid Drugs Market

• 27.1. Brazil Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anti-Thyroid Drugs Market

• 28.1. Middle East Anti-Thyroid Drugs Market Overview
• 28.2. Middle East Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anti-Thyroid Drugs Market

• 29.1. Africa Anti-Thyroid Drugs Market Overview
• 29.2. Africa Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anti-Thyroid Drugs Market Competitive Landscape And Company Profiles

• 30.1. Anti-Thyroid Drugs Market Competitive Landscape
• 30.2. Anti-Thyroid Drugs Market Company Profiles
  • 30.2.1. Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Anti-Thyroid Drugs Market Other Major And Innovative Companies

• 31.1. Pfizer Inc.
• 31.2. Allergan plc
• 31.3. RLC LABS Inc.
• 31.4. Amgen Inc.
• 31.5. Lannett Company Inc.
• 31.6. Sanofi S.A.
• 31.7. Novartis AG
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Eli Lilly and Company
• 31.10. Aspen Pharmacare Holdings Limited
• 31.11. Astellas Pharma Inc.
• 31.12. Takeda Pharmaceutical Company Limited
• 31.13. Boehringer Ingelheim GmbH
• 31.14. Daiichi Sankyo Company Limited
• 31.15. Roche Holding AG

32. Global Anti-Thyroid Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anti-Thyroid Drugs Market

34. Recent Developments In The Anti-Thyroid Drugs Market

35. Anti-Thyroid Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Anti-Thyroid Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Anti-Thyroid Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Anti-Thyroid Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer